National Institute of Health Office of Research on Drug Development and Regulation
GPTKB entity
Statements (82)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Research organization
|
| gptkbp:advocatesFor |
Patient safety
|
| gptkbp:aimsTo |
Improve drug approval processes
|
| gptkbp:analyzes |
Health outcomes
Clinical trial data Regulatory impacts Health policy impacts Market access issues Drug market trends Drug approval processes Clinical trial outcomes Drug safety data Drug market dynamics Drug pricing issues |
| gptkbp:collaboratesWith |
Government agencies
Research institutions Non-profit organizations Pharmaceutical companies |
| gptkbp:conducts |
Research on drug safety
Surveys on drug use Research on drug interactions Research on drug delivery systems Research on drug efficacy Workshops on drug development Workshops on drug regulation |
| gptkbp:coordinatesWith |
Health organizations
|
| gptkbp:develops |
Best practices
Educational materials Public health initiatives Regulatory frameworks Regulatory policies Training resources Guidelines for drug research |
| gptkbp:engagesIn |
Community outreach
Public health research Policy development Policy advocacy Public_outreach |
| gptkbp:established |
gptkb:National_Institutes_of_Health
|
| gptkbp:evaluates |
Drug efficacy
|
| gptkbp:facilitates |
Stakeholder engagement
Data sharing Interagency collaboration |
| gptkbp:focusesOn |
Drug development
Drug regulation |
| gptkbp:hosts |
Workshops
|
| https://www.w3.org/2000/01/rdf-schema#label |
National Institute of Health Office of Research on Drug Development and Regulation
|
| gptkbp:locatedIn |
gptkb:United_States
|
| gptkbp:monitors |
Drug development timelines
|
| gptkbp:offers |
Training programs
|
| gptkbp:participatesIn |
International collaborations
|
| gptkbp:partOf |
gptkb:National_Institutes_of_Health
|
| gptkbp:promotes |
Public health
Research integrity |
| gptkbp:provides |
Networking opportunities
Consultation services Technical assistance Technical guidance Guidance for researchers Information on clinical trials Consultation on drug policies Funding for drug research Guidance on clinical trials Information on drug policies Information on drug regulations Resources for clinical researchers Resources for drug researchers Support for drug innovation |
| gptkbp:publishes |
Research findings
|
| gptkbp:supports |
Clinical trials
Research collaborations Research funding initiatives Patient advocacy groups Drug safety initiatives Innovative research projects Research transparency Patient-centered research Regulatory science Innovative drug therapies Drug development research |
| gptkbp:worksWith |
gptkb:FDA
Academic institutions |